about
A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure.Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: a randomized, controlled trialSleep apnoea syndrome secondary to rheumatoid arthritisResponse to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial.Management of obstructive sleep apnea in Europe.Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP.Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation.Cerebral volumetric changes induced by prolonged hypoxic exposure and whole-body exerciseThe severity of nocturnal hypoxia but not abdominal adiposity is associated with insulin resistance in non-obese men with sleep apneaPublic health and medicolegal implications of sleep apnoea.Quadriceps and respiratory muscle fatigue following high-intensity cycling in COPD patients.Positive expiratory pressure improves oxygenation in healthy subjects exposed to hypoxiaChanges in voluntary activation assessed by transcranial magnetic stimulation during prolonged cycling exercise.Toll-like receptor-4 mediated inflammation is involved in the cardiometabolic alterations induced by intermittent hypoxia.Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 monthsVascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndromeObstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis.Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea.Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP.Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy.Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives.Short sleep duration is associated with a blood pressure nondipping pattern in type 1 diabetes: the DIAPASOM study.Sleep, sleep-disordered breathing and metabolic consequences.Sleep and pulmonary diseases.Sleep apnoea syndrome in 2011: current concepts and future directions.Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies.Cerebral perturbations during exercise in hypoxia.Stimulation of the motor cortex and corticospinal tract to assess human muscle fatigue.On treatment but still sleepy: cause and management of residual sleepiness in obstructive sleep apnea.Leukotrienes as a molecular link between obstructive sleep apnoea and atherosclerosis.Arterial stiffness in COPD.Hypertension and sleep: overview of a tight relationship.Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.Impact of exercise training without caloric restriction on inflammation, insulin resistance and visceral fat mass in obese adolescents.Significant improvement in arterial stiffness after endurance training in patients with COPD.Could the thromboxane A2 pathway be a therapeutic target for the treatment of obstructive sleep apnea-induced atherosclerosis?Prevention and care of respiratory failure in obese patients.Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep.Catalogue of knowledge and skills for sleep medicine.
P50
Q30480757-B5CDA944-3A29-489A-9CA3-4693B44F4212Q31023532-D7B57F45-108A-4A0D-BB24-09DB9D8744EDQ33441981-B7AA3159-0404-45B5-B87D-4846F466783FQ33605058-541BEE72-6824-4D8C-B5F9-4E0DB5B54A77Q34152828-48723782-4025-44B8-9DE7-DBEB0D2774BCQ34155503-60D3AFA8-AFAD-42C8-86E7-6F91EF40FD64Q34333932-ECF9A0D3-B8D7-4B1F-837A-ED52D17B81B2Q34558194-3373B137-369D-4E14-B875-79C20BC3C7AFQ34727474-B64CAB71-5751-44BE-8A17-5F1B67857DCFQ34948347-1BD1031F-569C-47B3-84CC-74E769EBC9EEQ35035029-20DD5BC6-A62C-4AFE-9E0D-B425ABA2E6DFQ35064339-AA701DB3-358A-4C31-8AE4-F9879B1A0E1FQ35078550-BA436676-0440-49B9-8876-EC9A1722CBBFQ35106759-DF7C901F-7FC9-4BD9-8339-C3C51B97A0AFQ35250450-7E5E4A33-1559-4723-81A4-942BD4AC93D0Q35563165-BDCFA83F-3DC7-4CE3-8950-1F00E8188E32Q35636669-59D48EC1-A7FB-411D-9C82-022D1F6044DDQ36055240-A779E8A8-A570-43E5-B5B8-FC83A57A6970Q36145246-A5FC44FF-C742-412A-A157-EEE316F55011Q36340657-EF64027B-F4B7-43B3-835A-765B97CDFE55Q36352734-D81A2562-80BA-4449-98F5-7A7FD77A7AF7Q37283117-3FE5B758-A843-4914-A98A-57891B720AB8Q37319138-5A7DDE0D-6150-4701-ADEB-2979403168DFQ37536555-E5B77C16-9371-40C0-9C2D-09A3AE25E824Q37807691-C6E54868-4CA3-41B8-9737-B986A42B2EF6Q37924449-7CF7E8B8-188D-44E0-9155-0011B9EEEF2AQ37961776-6266EB91-640F-41B6-9A2A-A21B48A44552Q37982684-50648BE0-A682-4962-9ACB-804E17B3E84BQ38058200-D410CEA9-C9C9-4E81-9176-70F9BD2F69DBQ38141600-AC7EB5A8-C9A6-4CF9-BC93-C863DA4B9B17Q38160826-BC709D30-231A-42BE-A569-040BD762575EQ38200962-06BA8DB1-B2E4-4D85-9C82-C1B51065CDDAQ38213350-37116CCE-7F22-433B-9DC2-D3A4BC719C51Q38249122-2B1CFE0F-AB10-4A4C-B42F-7CF1B6DF963DQ38305299-17D04173-4447-4C80-A0BD-62D885C409D5Q38377998-9C3AAB1D-2FD7-40AB-B453-8E0852BF4790Q38508807-95DFC4B7-C0E7-41AA-954A-149968953E01Q38865784-612CF447-4159-4F60-9CC7-6DDC1CD980C4Q39030006-9F8428EE-8012-404A-A242-7B6DE5EF3DB6Q39334442-C1AC7597-A7DA-45FC-B4B4-53276C27EA3E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Patrick Lévy
@ast
Patrick Lévy
@en
Patrick Lévy
@es
Patrick Lévy
@nl
Patrick Lévy
@sl
type
label
Patrick Lévy
@ast
Patrick Lévy
@en
Patrick Lévy
@es
Patrick Lévy
@nl
Patrick Lévy
@sl
prefLabel
Patrick Lévy
@ast
Patrick Lévy
@en
Patrick Lévy
@es
Patrick Lévy
@nl
Patrick Lévy
@sl
P1006
P214
P244
P1006
P106
P1153
7202556569
P21
P213
0000 0001 1568 4984
P214
P244
no97020568
P31
P496
0000-0003-3174-7935
P735
P7859
lccn-no97020568